You can watch Goldberg full announcement in the video above. The post Whoopi Goldberg Joins Italian Soap Opera in Recurring Role: ‘I Know It’s a Crazy Idea’ appeared first on TheWrap.

Xero announced a deal to acquire small business payments platform Melio for $2.5 billion and fill a gap in its offerings by integrating accounting and bill payments.

Chanticleer Inside Xero’s $4b bet to finally crack the US market CEO Sukhinder Singh Cassidy is doing the sort of deal fund managers are usually wary of. But she’s determined to double the ...

The best free invoice generators can simplify billing, track payments and get you paid faster. Here’s what to know about the best free invoice and billing software available.

US$2.5b deal will double Xero revenues by 2028, says CEO Analysts say Xero is paying a high multiple to buy US payments company Melio, but are positive about the strategy and the growth prospects.

Wellington-based Xero plans to buy Melio, a leading US-Israeli business-to-business bill paying platform, in a cash and share deal worth US$2.5 billion ($4.1b).

Xero has entered into a binding agreement to acquire Melio, a leading US bill payment platform for small and medium-sized businesses, for US$2.5 billion (NZ$4.1B).

When Paula Comings, the head of currency sales for US Bancorp, talks to US importers, she increasingly hears the same message: Their foreign counterparties no longer want to be paid in dollars.

OpenAI says it recently hit $10 billion in annual recurring revenue, up from around $5.5 billion last year.

Instead of paying the standard $99.99 fee for access to Microsoft 365, you can own your most-used apps, like Word, Excel, and PowerPoint, for only $129.97 with Microsoft Office 2024.

Offline training simulator for Xero accounting software — manage invoices, expenses, and reports in a desktop-style layout without login or internet. xero accounting offline, simulate bookkeeping ...

An immunotherapy drug could help some cancer patients live years longer without the disease worsening or recurring, according to a new trial.